financetom
Business
financetom
/
Business
/
Aramark Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Fiscal 2026 Outlook
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Aramark Fiscal Q4 Adjusted Earnings, Revenue Rise; Issues Fiscal 2026 Outlook
Nov 17, 2025 4:10 AM

06:56 AM EST, 11/17/2025 (MT Newswires) -- Aramark ( ARMK ) reported fiscal Q4 adjusted earnings Monday of $0.57 per diluted share, up from $0.54 a year earlier.

Analysts polled by FactSet expected $0.64.

Revenue for the quarter ended Oct. 3 was $5.05 billion, compared with $4.42 billion a year earlier.

Analysts surveyed by FactSet expected $5.16 billion.

For fiscal 2026, the company said it expects adjusted EPS of $2.18 to $2.28. Analysts polled by FactSet expect $2.27.

Revenue for the fiscal year is projected to be $19.55 billion to $19.95 billion. Analysts surveyed by FactSet expect $19.69 billion.

Shares of the company were down 5.3% in recent Monday premarket activity.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Correction: --Microsoft CCO Says AI Saved Company $500 Million Last Year in Call Centers, Bloomberg Reports
Correction: --Microsoft CCO Says AI Saved Company $500 Million Last Year in Call Centers, Bloomberg Reports
Jul 9, 2025
01:38 PM EDT, 07/09/2025 (MT Newswires) -- Price: 501.85, Change: +5.23, Percent Change: +1.05 ...
Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise
Rhythm Pharma's Oral Drug For Rare Obesity Shows Promise
Jul 9, 2025
Rhythm Pharmaceuticals, Inc. ( RYTM ) on Wednesday released topline results from its Phase 2 trial evaluating bivamelagon (formerly LB54640), an investigational oral melanocortin-4 receptor (MC4R) agonist, in patients with acquired hypothalamic obesity. Hypothalamic obesity is a rare type of obesity resulting from damage to the hypothalamus, a brain region that regulates appetite and metabolism. Bivamelagon achieved statistically significant and...
Tesla investors ask board to set date for overdue annual shareholder meeting
Tesla investors ask board to set date for overdue annual shareholder meeting
Jul 9, 2025
(Reuters) -A group of 27 major Tesla shareholders urged the electric automaker's board on Wednesday to set a date for its annual shareholder meeting this year, citing legal obligations and growing governance concerns. Tesla is close to missing a legal deadline and has not announced this year's meeting, the group consisting of U.S. state treasurers, pension funds and governance experts...
Copyright 2023-2026 - www.financetom.com All Rights Reserved